Concomitant dose escalation with image-guided Tomotherapy in locally advanced mid–low rectal cancer: a single-center study

References

• BossetJ-FColletteLCalaisGChemotherapy with preoperative radiotherapy in rectal cancerN Engl J Med Overseas Ed20063551111141123
   PubMed Web of Science ®Google Scholar
• SauerRLierschTMerkelSPreoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 yearsJ Clin Oncol201230161926193322529255
   PubMed Web of Science ®Google Scholar
• SauerRBeckerHHohenbergerWPreoperative versus postoperative chemoradiotherapy for rectal cancerN Engl J Med2004351171731174015496622
   PubMed Web of Science ®Google Scholar
• ParkIJYouYNAgarwalANeoadjuvant treatment response as an early response indicator for patients with rectal cancerJ Clin Oncol201230151770177622493423
   PubMed Web of Science ®Google Scholar
• DengYChiPLanPModified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phase III trialJ Clin Oncol201634273300330727480145
   PubMed Web of Science ®Google Scholar
• AscheleCCioniniLLonardiSPrimary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trialJ Clin Oncol201129202773278021606427
   PubMed Web of Science ®Google Scholar
• GérardJPAzriaDGourgou-BourgadeSClinical outcome of the Accord 12/0405 PRODIGE 2 randomized trial in rectal cancerJ Clin Oncol201230364558456523109696
   PubMed Web of Science ®Google Scholar
• RödelCLierschTBeckerHPreoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trialLancet Oncol201213767968722627104
   PubMed Web of Science ®Google Scholar
• FokasELierschTFietkauRTumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trialJ Clin Oncol201432151554156224752056
   PubMed Web of Science ®Google Scholar
• O’ConnellMJColangeloLHBeartRWCapecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from national surgical adjuvant breast and bowel project trial R-04J Clin Oncol201432181927193424799484
   PubMed Web of Science ®Google Scholar
• AllegraCJYothersGO’ConnellMJNeoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: a phase III randomized clinical trialJ Natl Cancer Inst201510711djv24826374429
   PubMedGoogle Scholar
• RödelCGraevenUFietkauROxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trialLancet Oncol201516897998926189067
   PubMed Web of Science ®Google Scholar
• AppeltALSebag-MontefioreDTechnological advances in radiotherapy of rectal cancer: opportunities and challengesCurr Opin Oncol201628435335827153356
   PubMed Web of Science ®Google Scholar
• SermeusAEngelsBUrbainDDe RidderMAdvances in radiotherapy delivery for rectal cancer: a European perspectiveExpert Rev Gastroenterol Hepatol20159439339725644307
   PubMed Web of Science ®Google Scholar
• LiJLJiJFCaiYPreoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trialRadiother Oncol201210214921903285
   PubMed Web of Science ®Google Scholar
• ZhuJLiuFGuWConcomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II studyRadiat Oncol2014917024606870
   PubMedGoogle Scholar
• But-HadzicJAnderluhFBreceljEAcute toxicity and tumor response in locally advanced rectal cancer after preoperative chemoradiation therapy with shortening of the overall treatment time using intensity-modulated radiation therapy with simultaneous integrated boost: a phase 2 trialInt J Radiat Oncol Biol Phys20169651003101027727065
   PubMed Web of Science ®Google Scholar
• TeyJLeongCNCheongWKA phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancerJ Cancer20178163114312129158782
   PubMed Web of Science ®Google Scholar
• BurbachJPden HarderAMIntvenMvan VulpenMVerkooijenHMReerinkOImpact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysisRadiother Oncol201411311925281582
   PubMed Web of Science ®Google Scholar
• HuKLiWHouXThe efficacy of neoadjuvant concurrent chemoradiotherapy or radiotherapy alone in patients with locally advanced rectal cancerChin J Radiat Oncol2011206502505
   Google Scholar
• LupattelliMMatroneFGambacortaMAPreoperative intensity-modulated radiotherapy with a simultaneous integrated boost combined with capecitabine in locally advanced rectal cancer: short-term results of a multicentric studyRadiat Oncol201712113928830475
   PubMedGoogle Scholar
• StuyckCWeggeMBulensPJoyeIHaustermansKModerate dose escalation with volumetric modulated Arc therapy improves outcome in rectal cancerActa Oncol201756111501150628826304
   PubMed Web of Science ®Google Scholar
• BaeBKKangMKKimJCSimultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancerRadiat Oncol J201735320821629037023
   PubMedGoogle Scholar
• LinJCTsaiJTChenLJLiMHLiuWHCompared planning dosimetry of TOMO, VMAT and IMRT in rectal cancer with different simulated positionsOncotarget2017826420204202928159930
   PubMedGoogle Scholar
• TournelKDe RidderMEngelsBAssessment of intrafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomographyInt J Radiat Oncol Biol Phys200871393493918514785
   PubMed Web of Science ®Google Scholar
• EngelsBDe RidderMTournelKPreoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: impact on the irradiated volume of small bowelInt J Radiat Oncol Biol Phys20097451476148019231097
   PubMed Web of Science ®Google Scholar
• De RidderMTournelKVan NieuwenhoveYPhase II study of preoperative helical tomotherapy for rectal cancerInt J Radiat Oncol Biol Phys200870372873417904302
   PubMed Web of Science ®Google Scholar
• EngelsBTournelKEveraertHPhase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancerInt J Radiat Oncol Biol Phys201283114214822014952
   PubMed Web of Science ®Google Scholar
• HuangCMHuangMYTsaiHLA retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinomaJ Radiat Res201758224725927738080
   PubMed Web of Science ®Google Scholar
• EngelsBPlatteauxNVan den BeginRPreoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcomeRadiother Oncol2014110115515924239243
   PubMed Web of Science ®Google Scholar
• HuangMYChenCFHuangCMHelical tomotherapy combined with capecitabine in the preoperative treatment of locally advanced rectal cancerBiomed Res Int201420148112
   Google Scholar
• BurbachJPVerkooijenHMIntvenMRandomized controlled trial for pre-operAtive dose-escaLation boost in locally advanced rectal cancer (rectal boost study): study protocol for a randomized controlled trialTrials20151615825888548
   PubMedGoogle Scholar